Josh Long

The human foods chief for the U.S. Food and Drug Administration on Tuesday reiterated FDA’s commitment to working with U.S. lawmakers on authority to require manufacturers of dietary supplements to list their products with the agency.

Officials with the U.S. Food and Drug Administration have been consistent with their position regarding whether kratom can be marketed in dietary supplement products.

An education and networking event at SupplySide West featuring representatives from FDA and six trade groups will explore 30 years of DSHEA and how to move the industry forward.

The U.S. Hemp Roundtable and hemp farmers and businesses on Tuesday filed a lawsuit in Los Angeles County Superior Court, challenging emergency rules that plaintiffs contend will shatter a burgeoning industry.

The “single largest reorganization” in the “modern history” of the U.S. Food and Drug Administration is now in effect, top agency officials announced Tuesday.

Hi, JVM fans! In this installment, I talk to Bruce Eckel, who wrote - among countless other classics - "Thinking in Java" and "Thinking in C++," both

Move over kratom leaf and kratom extracts. Products containing 7-hydroxymitragynine are in high demand, according to a major producer of 7-OH.

The Natural Products Association and the U.S. Food and Drug Administration are in a fight over the legality of a healthy aging ingredient (NMN) — and now a pharmaceutical company wants to join the battle.

The New Jersey General Assembly on Monday, Oct. 28, passed a bill that prohibits the sale to minors of certain dietary supplement products unless the minor is accompanied by a parent or guardian. There is no companion bill in the state Senate.

A federal court in Washington, D.C., has granted a stay in a lawsuit against the U.S. Food and Drug Administration concerning the legality of a healthy aging ingredient (NMN) marketed in dietary supplement products.